Biotechnology - Berkeley, California, United States
ImmunoMind helps select the best T-cell therapy candidates early by assessing and comparing their designs with single-cell precision. ImmunoMind's Augmented Intelligence platform is based on proprietary single-cell multi-omics technologies to automatically evaluate 14 essential T-cell population characteristics – exhaustion, persistence, immune profile, and more. The platform guides translational and clinical research to improve the probability of success in later drug development stages.UC Berkeley SkyDeck'20 Alumnus.
Gmail
Nginx
Mobile Friendly
Amazon AWS